By G HossainPosted on October 2, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments. How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio Post navigation Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners TogetherThe myth of meritocracy